Showing results (611-620 of 844) with videos related to
Sort By:
Pageof 85
Cancer|May 21, 2011
Hormone-receptor expression and activity of trastuzumab with chemotherapy in HER2-positive advanced breast cancer patientsFilippo Montemurro, Valentina Rossi, Maria Cossu Rocca, et al.Medical Care|March 1, 1996
Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an international adjuvant breast cancer trialC Hürny, J Bernhard, A Coates, et al.Lancet (London, England)|April 20, 1996
Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survivalR D Gelber, B F Cole, A Goldhirsch, et al.Breast Cancer Research : BCR|June 22, 2014
Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypesPatrick Maisonneuve, Davide Disalvatore, Nicole Rotmensz, et al.Anticancer Research|July 11, 2006
Vinorelbine-based chemotherapy in hormone-refractory prostate cancerM G Zampino, E Verri, M Locatelli, et al.Clinical Breast Cancer|August 11, 2015
Outcome and Medial Presentation of Breast Cancer: European Institute of Oncology ExperienceEmilia Montagna, Vincenzo Bagnardi, Nicole Rotmensz, et al.Anticancer Research|November 5, 2014
Does immediate breast reconstruction after mastectomy and neoadjuvant chemotherapy influence the outcome of patients with non-endocrine responsive breast cancer?Gaetano Aurilio, Vincenzo Bagnardi, Rossella Graffeo, et al.Breast (Edinburgh, Scotland)|June 30, 2022
Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51DR Graffeo, H Q Rana, F Conforti, et al.Lancet (London, England)|January 8, 2008
Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials, M Clarke, A S Coates, et al.Health Science Reports|November 10, 2021
Clinical presentation, complications, and outcomes of hospitalized COVID-19 patients in an academic center with a centralized palliative care consult serviceSarah M Baker, Doug J Leedy, Jesse Abbott Klafter, et al.Pageof 85